Intravenous Infusion Pump Market Segments - by Product Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Peristaltic Infusion Pumps, Ambulatory Infusion Pumps, Implantable Infusion Pumps), Application (Chemotherapy, Diabetes, Gastroenterology, Pediatrics, Analgesia), Distribution Channel (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Homecare Settings, Online Sales), Technology (Traditional Infusion Pumps, Smart Infusion Pumps, Specialty Infusion Pumps), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2035

Intravenous Infusion Pump Sales

Intravenous Infusion Pump Market Segments - by Product Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Peristaltic Infusion Pumps, Ambulatory Infusion Pumps, Implantable Infusion Pumps), Application (Chemotherapy, Diabetes, Gastroenterology, Pediatrics, Analgesia), Distribution Channel (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Homecare Settings, Online Sales), Technology (Traditional Infusion Pumps, Smart Infusion Pumps, Specialty Infusion Pumps), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2035

Intravenous Infusion Pump Sales Market Outlook

The global intravenous infusion pump market was valued at approximately USD 5 billion in 2023, with an anticipated growth rate (CAGR) of around 7% from 2025 to 2035. This upward trajectory can be attributed to the increasing prevalence of chronic diseases and the rising demand for effective drug delivery systems within healthcare settings. Furthermore, the growing geriatric population, which typically requires more extensive medical care, is fostering a higher dependency on infusion pumps. Advances in technology such as smart infusion pumps, which enhance safety and efficacy in medication delivery, are also driving market growth. The increasing emphasis on patient safety and the reduction of medication errors is another pivotal factor contributing to the expansion of the intravenous infusion pump market.

Growth Factor of the Market

The growth of the intravenous infusion pump market is significantly driven by several interrelated factors. Firstly, the rising incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases has led to an increased demand for precise drug delivery methods. Hospitals and healthcare providers are increasingly adopting advanced infusion systems to improve patient outcomes and operational efficiency. Secondly, technological advancements, particularly in the development of smart infusion pumps equipped with advanced safety features, have made infusion therapies more effective and safer, attracting healthcare institutions to upgrade their existing equipment. The ongoing emphasis on minimizing medication errors and improving patient safety protocols has further bolstered the market's expansion. Additionally, the growing trend towards home healthcare services is also contributing to the rising demand, as patients require reliable and efficient infusion systems for at-home treatments.

Key Highlights of the Market
  • Projected CAGR of around 7% from 2025 to 2035.
  • Significant increase in demand for smart infusion pumps due to enhanced safety features.
  • Rising prevalence of chronic diseases necessitating effective medication delivery.
  • Expansion of home healthcare services driving market growth.
  • Technological innovations improving the efficiency of intravenous therapies.

By Product Type

Volumetric Infusion Pumps:

Volumetric infusion pumps are essential devices that allow precise regulation of fluid delivery to patients by controlling the volume and rate of infusion. They are predominantly employed in hospital settings for various applications, including intravenous therapy, blood transfusions, and medication administration. Their capability to provide continuous or intermittent infusion makes them a critical component in managing patient care efficiently. Moreover, volumetric pumps are designed with advanced technology that often includes alarms for occlusion, air in the line, and other malfunctions, thereby enhancing patient safety.

Syringe Infusion Pumps:

Syringe infusion pumps are specialized devices designed for the administration of small volumes of medication precisely and accurately. These pumps are particularly important in pediatric and neonatal care, where dosage accuracy is crucial. Syringe pumps offer the ability to deliver medications over extended periods, making them suitable for continuous infusions. Their compact size and portability also make them ideal for use in various healthcare settings, including hospitals and outpatient clinics, where space constraints may exist. The growing adoption of syringe pumps is driven by their reliability and the increasing need for individualized patient therapy.

Peristaltic Infusion Pumps:

Peristaltic infusion pumps utilize a unique mechanism to move fluids through flexible tubing by compressing and releasing the tubing, creating a peristaltic action. This design minimizes the risk of contamination, making it suitable for delivering sensitive medications and biological fluids. These pumps are commonly used in various applications, including laboratory settings and specialized medical procedures. The rising demand for peristaltic pumps is attributed to their ease of use, flexibility, and ability to handle various fluid types without the risk of backflow or contamination.

Ambulatory Infusion Pumps:

Ambulatory infusion pumps are portable devices designed for patients who require continuous infusion therapy while allowing them the freedom to move and engage in daily activities. These pumps are particularly beneficial for patients undergoing long-term treatment for chronic conditions, such as cancer or diabetes. The convenience and mobility offered by ambulatory pumps promote better patient compliance and improve overall quality of life. The increasing focus on patient-centered care and the growing trend of outpatient treatment are driving the adoption of ambulatory infusion pumps across healthcare settings.

Implantable Infusion Pumps:

Implantable infusion pumps represent a specialized segment within the intravenous infusion pump market, designed for long-term drug delivery through subcutaneous implantation. These devices are particularly beneficial for patients requiring consistent administration of medications, such as pain management or chemotherapy agents. The advanced design of implantable pumps allows for controlled release of drugs, reducing the frequency of administration and enhancing patient comfort. The growing prevalence of chronic pain management and the need for continuous drug delivery solutions are propelling the market for implantable infusion pumps.

By Application

Chemotherapy:

The application of intravenous infusion pumps in chemotherapy is critical for the administration of anticancer drugs that require precise dosing and scheduling. Infusion pumps facilitate continuous or intermittent drug delivery, which is essential for managing side effects and enhancing therapeutic efficacy. The increasing incidence of cancer worldwide is driving the demand for advanced chemotherapy infusion systems that ensure accurate dosing. Furthermore, the integration of smart technology in infusion pumps helps monitor patient responses and adjust dosages accordingly, thereby improving treatment outcomes.

Diabetes:

In diabetes management, intravenous infusion pumps are utilized to deliver insulin or other medications with high precision, enabling patients to maintain optimal blood glucose levels. These pumps offer programmable delivery rates, allowing tailored therapy based on individual patient needs. The growing prevalence of diabetes globally is contributing to the increasing adoption of insulin infusion pumps, as they enhance patient compliance and reduce the risks associated with traditional syringe or manual injections. With an expanding focus on personalized medicine, the future of infusion pumps in diabetes care appears promising.

Gastroenterology:

Intravenous infusion pumps are widely used in gastroenterology for the administration of medications related to gastrointestinal disorders, such as inflammatory bowel disease or nutritional support in patients unable to ingest food orally. These pumps allow healthcare providers to administer nutrients and medications continuously, ensuring that patients receive the necessary care without interruption. The growing awareness of gastrointestinal diseases and the need for effective management strategies are driving the demand for infusion pumps in this application, as healthcare providers increasingly rely on these devices to improve patient outcomes.

Pediatrics:

Pediatric patients often require specialized care, making intravenous infusion pumps an essential tool for administering medications and fluids accurately and safely. The precise delivery capabilities of infusion pumps are crucial in managing the unique physiological needs of children, who can be more susceptible to medication errors. The rising incidence of pediatric chronic conditions and the increasing focus on tailored treatment protocols are contributing to the growing demand for infusion pumps in pediatric settings. This segment is highly influenced by advancements in technology that enhance safety and usability.

Analgesia:

In the field of pain management, intravenous infusion pumps play a vital role in delivering analgesic medications effectively. These pumps can provide continuous delivery of pain relief medications, such as opioids, ensuring that patients experience minimal discomfort during treatment. The increasing recognition of the importance of effective pain management, especially in postoperative care and patients with chronic pain, is driving the demand for infusion pumps in this application. By facilitating precise dosing and minimizing the risk of overdose, infusion pumps are revolutionizing how pain is managed in clinical settings.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for intravenous infusion pumps, accounting for a significant share of the market. The high demand for advanced medical equipment in hospital settings, particularly in intensive care units and surgical wards, drives the sales of infusion pumps. Hospitals invest in modern infusion systems to enhance patient safety and ensure effective medication delivery. The ongoing expansion of healthcare facilities and the increasing emphasis on quality care are propelling the growth of this segment, as hospitals seek to upgrade their equipment to meet evolving clinical needs.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly adopting intravenous infusion pumps due to the growing trend towards outpatient surgeries and procedures. These centers require efficient and reliable infusion systems to manage patients' medications during surgical and recovery phases. The convenience and cost-effectiveness of ASCs are driving their popularity, leading to an increased demand for infusion pumps tailored to outpatient care. As ASCs seek to provide high-quality services with a focus on patient comfort and safety, the infusion pump market in this segment is expected to grow significantly.

Specialty Clinics:

Specialty clinics, such as those focusing on oncology, diabetes, or pain management, are key distribution channels for intravenous infusion pumps. These clinics often require specialized infusion systems to cater to the unique needs of their patient populations. The demand for tailored infusion therapies in specialty clinics is increasing, driven by the rising prevalence of chronic conditions and the need for personalized treatment plans. By investing in innovative infusion technologies, specialty clinics aim to enhance patient experiences and outcomes, thus solidifying their role in the market.

Homecare Settings:

The homecare setting is a rapidly growing distribution channel for intravenous infusion pumps, largely driven by the trend towards at-home healthcare services. Patients requiring long-term therapy, such as those undergoing chemotherapy or managing chronic pain, often benefit from the convenience of home-based infusion systems. This shift towards homecare reduces the burden on hospitals and improves patients' quality of life. The demand for portable and user-friendly infusion pumps designed for home use is expected to rise significantly as healthcare providers increasingly adopt homecare strategies.

Online Sales:

The online sales channel for intravenous infusion pumps is gaining traction as healthcare providers and organizations increasingly turn to e-commerce platforms for procurement. This trend is influenced by the convenience and accessibility that online purchasing offers, allowing providers to quickly source essential medical equipment. The growing emphasis on digital healthcare solutions and the rising number of healthcare suppliers operating online are contributing to the expansion of this distribution channel. As healthcare continues to evolve towards digitalization, online sales of infusion pumps are expected to play a crucial role in enhancing supply chain efficiency.

By Technology

Traditional Infusion Pumps:

Traditional infusion pumps have been the backbone of intravenous therapy for decades, providing healthcare providers with reliable and effective medication delivery systems. These pumps are designed to deliver fluids and medications at predetermined rates, allowing for consistency in patient care. Despite their effectiveness, traditional pumps may lack some of the advanced safety features found in newer technologies, which can lead to a higher risk of medication errors. However, they remain widely used due to their simplicity and proven track record, especially in settings where advanced features are not required.

Smart Infusion Pumps:

Smart infusion pumps are revolutionizing the intravenous infusion landscape by integrating advanced technology to enhance safety and efficiency. These pumps are equipped with features such as drug libraries, dose error reduction systems, and real-time monitoring capabilities. Smart pumps significantly reduce the risk of medication errors by alerting healthcare providers when discrepancies occur in infusion rates or dosages. The increasing focus on patient safety, combined with the growing adoption of electronic health records and integrated healthcare systems, is driving the demand for smart infusion pumps in various clinical settings.

Specialty Infusion Pumps:

Specialty infusion pumps address the unique needs of specific patient populations or treatment modalities, such as chemotherapy or pain management. These pumps are designed with specialized features to optimize drug delivery for particular therapies, ensuring patients receive the most effective treatment possible. The growth in personalized medicine and the increasing prevalence of chronic diseases are contributing to the rising demand for specialty infusion pumps. As healthcare providers seek to enhance patient outcomes through tailored infusion therapies, the market for specialty pumps is expected to expand significantly.

By Region

In North America, the intravenous infusion pump market is projected to maintain its dominant position, driven by the presence of advanced healthcare infrastructure and a high prevalence of chronic diseases. This region is anticipated to account for over 40% of the global market share by 2035, with a CAGR of approximately 6% during the forecast period. The increasing adoption of smart infusion technology and the emphasis on patient safety measures are key factors propelling growth in this region. Additionally, the growing geriatric population, coupled with advancements in healthcare technology, is expected to further boost the demand for infusion pumps.

Europe is also witnessing significant growth in the intravenous infusion pump market, expected to capture around 30% of the global share by 2035. Factors such as the rising incidence of chronic diseases, increased healthcare spending, and a growing preference for home healthcare solutions are propelling this growth. The region's focus on enhancing healthcare delivery systems, coupled with the introduction of innovative infusion technologies, is anticipated to drive up the demand for infusion pumps. Countries such as Germany, France, and the UK are leading contributors to the market's growth within Europe, supporting advanced healthcare practices and technological adoption.

Opportunities

The intravenous infusion pump market presents numerous opportunities for growth and innovation. One of the most significant opportunities lies in the development of smart infusion pumps that leverage IoT technology. These advanced devices can provide real-time data monitoring and analytics, enabling healthcare providers to optimize treatment plans and improve patient outcomes. As telehealth and remote patient monitoring continue to gain traction, the demand for smart infusion systems is expected to increase, allowing patients to receive high-quality care in the comfort of their homes. This convergence of technology and healthcare opens up new avenues for companies to innovate and create solutions that address the evolving needs of patients and providers alike.

Furthermore, there is a growing opportunity for market players to expand their presence in emerging markets. As healthcare infrastructure improves in regions such as Asia Pacific and Latin America, the demand for intravenous infusion pumps is expected to rise significantly. Companies that can adapt to local market dynamics and provide affordable yet effective infusion solutions will likely capture a substantial share of these expanding markets. Additionally, partnerships with local healthcare providers and governments can facilitate market entry and ensure that products meet the specific needs of diverse patient populations, driving further growth in the intravenous infusion pump market.

Threats

Despite the promising growth prospects, the intravenous infusion pump market faces several threats that could hinder its expansion. One significant concern is the increasing prevalence of product recalls and safety concerns associated with infusion pumps. Instances of malfunction or programming errors can lead to serious patient safety issues, resulting in regulatory scrutiny and potential legal liabilities for manufacturers. As healthcare providers become more cautious in their purchasing decisions, this could impact the overall demand for infusion pumps. Additionally, the competitive landscape is intensifying, with numerous players vying for market share, which could lead to price wars and reduced profitability for manufacturers.

Another potential restraining factor for the intravenous infusion pump market is the rising costs associated with procurement and maintenance. Healthcare facilities are under immense pressure to control costs, and the high initial investment required for advanced infusion systems may deter some organizations from upgrading their equipment. Furthermore, the ongoing demand for continuous training and support for healthcare staff to effectively use these advanced pumps can add to the total cost of ownership. In such a competitive environment, companies must demonstrate the value of their products to healthcare providers to overcome these challenges and maintain market presence.

Competitor Outlook

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Medtronic plc
  • Smiths Medical
  • ICU Medical, Inc.
  • Fresenius Kabi AG
  • Terumo Corporation
  • CareFusion Corporation
  • Johnson & Johnson
  • Moog Inc.
  • Halyard Health, Inc.
  • GE Healthcare
  • Philips Healthcare
  • Hospira, Inc.
  • Zyno Medical, LLC

The competitive landscape in the intravenous infusion pump market is characterized by the presence of several established players and emerging companies. Major corporations such as Abbott Laboratories and Medtronic continue to lead the market, thanks to their comprehensive portfolios of infusion systems and commitment to innovation. These companies invest heavily in research and development to enhance their product offerings and maintain their competitive edge. Moreover, collaborations and strategic partnerships among key players are becoming increasingly common, as companies seek to leverage each other's strengths and capabilities to deliver cutting-edge solutions to healthcare providers.

ICU Medical, Inc. has emerged as a strong competitor in the intravenous infusion pump market, particularly following its acquisition of the infusion systems business from Hospira. This strategic move has bolstered ICU Medical's position in the market and expanded its product offerings to cover a wider range of infusion therapies. The company's focus on developing smart infusion technologies and enhancing patient safety aligns well with current market trends, making it a formidable competitor. Additionally, companies like B. Braun and Fresenius Kabi are focusing on expanding their product lines and enhancing the functionality of their infusion pumps to cater to the evolving needs of healthcare providers.

Emerging players, such as Zyno Medical, are also gaining traction in the market by offering innovative solutions at competitive prices. Zyno Medical specializes in developing portable infusion pumps that are designed for homecare settings, catering to the growing demand for at-home healthcare solutions. Their focus on user-friendly designs and advanced features positions them well in a rapidly evolving market. As competition intensifies, companies are increasingly looking for ways to differentiate themselves through unique product offerings, improved service capabilities, and strategic alliances with healthcare providers.

  • 1 Appendix
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 Market Definition
    • 2.2 Scope of the Report
    • 2.3 Study Assumptions
    • 2.4 Base Currency & Forecast Periods
  • 3 Market Dynamics
    • 3.1 Market Growth Factors
    • 3.2 Economic & Global Events
    • 3.3 Innovation Trends
    • 3.4 Supply Chain Analysis
  • 4 Consumer Behavior
    • 4.1 Market Trends
    • 4.2 Pricing Analysis
    • 4.3 Buyer Insights
  • 5 Key Player Profiles
    • 5.1 Moog Inc.
      • 5.1.1 Business Overview
      • 5.1.2 Products & Services
      • 5.1.3 Financials
      • 5.1.4 Recent Developments
      • 5.1.5 SWOT Analysis
    • 5.2 GE Healthcare
      • 5.2.1 Business Overview
      • 5.2.2 Products & Services
      • 5.2.3 Financials
      • 5.2.4 Recent Developments
      • 5.2.5 SWOT Analysis
    • 5.3 Hospira, Inc.
      • 5.3.1 Business Overview
      • 5.3.2 Products & Services
      • 5.3.3 Financials
      • 5.3.4 Recent Developments
      • 5.3.5 SWOT Analysis
    • 5.4 Medtronic plc
      • 5.4.1 Business Overview
      • 5.4.2 Products & Services
      • 5.4.3 Financials
      • 5.4.4 Recent Developments
      • 5.4.5 SWOT Analysis
    • 5.5 Smiths Medical
      • 5.5.1 Business Overview
      • 5.5.2 Products & Services
      • 5.5.3 Financials
      • 5.5.4 Recent Developments
      • 5.5.5 SWOT Analysis
    • 5.6 Fresenius Kabi AG
      • 5.6.1 Business Overview
      • 5.6.2 Products & Services
      • 5.6.3 Financials
      • 5.6.4 Recent Developments
      • 5.6.5 SWOT Analysis
    • 5.7 ICU Medical, Inc.
      • 5.7.1 Business Overview
      • 5.7.2 Products & Services
      • 5.7.3 Financials
      • 5.7.4 Recent Developments
      • 5.7.5 SWOT Analysis
    • 5.8 Johnson & Johnson
      • 5.8.1 Business Overview
      • 5.8.2 Products & Services
      • 5.8.3 Financials
      • 5.8.4 Recent Developments
      • 5.8.5 SWOT Analysis
    • 5.9 Zyno Medical, LLC
      • 5.9.1 Business Overview
      • 5.9.2 Products & Services
      • 5.9.3 Financials
      • 5.9.4 Recent Developments
      • 5.9.5 SWOT Analysis
    • 5.10 Philips Healthcare
      • 5.10.1 Business Overview
      • 5.10.2 Products & Services
      • 5.10.3 Financials
      • 5.10.4 Recent Developments
      • 5.10.5 SWOT Analysis
    • 5.11 Terumo Corporation
      • 5.11.1 Business Overview
      • 5.11.2 Products & Services
      • 5.11.3 Financials
      • 5.11.4 Recent Developments
      • 5.11.5 SWOT Analysis
    • 5.12 Abbott Laboratories
      • 5.12.1 Business Overview
      • 5.12.2 Products & Services
      • 5.12.3 Financials
      • 5.12.4 Recent Developments
      • 5.12.5 SWOT Analysis
    • 5.13 Halyard Health, Inc.
      • 5.13.1 Business Overview
      • 5.13.2 Products & Services
      • 5.13.3 Financials
      • 5.13.4 Recent Developments
      • 5.13.5 SWOT Analysis
    • 5.14 B. Braun Melsungen AG
      • 5.14.1 Business Overview
      • 5.14.2 Products & Services
      • 5.14.3 Financials
      • 5.14.4 Recent Developments
      • 5.14.5 SWOT Analysis
    • 5.15 CareFusion Corporation
      • 5.15.1 Business Overview
      • 5.15.2 Products & Services
      • 5.15.3 Financials
      • 5.15.4 Recent Developments
      • 5.15.5 SWOT Analysis
  • 6 Market Segmentation
    • 6.1 Intravenous Infusion Pump Sales Market, By Technology
      • 6.1.1 Traditional Infusion Pumps
      • 6.1.2 Smart Infusion Pumps
      • 6.1.3 Specialty Infusion Pumps
    • 6.2 Intravenous Infusion Pump Sales Market, By Application
      • 6.2.1 Chemotherapy
      • 6.2.2 Diabetes
      • 6.2.3 Gastroenterology
      • 6.2.4 Pediatrics
      • 6.2.5 Analgesia
    • 6.3 Intravenous Infusion Pump Sales Market, By Product Type
      • 6.3.1 Volumetric Infusion Pumps
      • 6.3.2 Syringe Infusion Pumps
      • 6.3.3 Peristaltic Infusion Pumps
      • 6.3.4 Ambulatory Infusion Pumps
      • 6.3.5 Implantable Infusion Pumps
    • 6.4 Intravenous Infusion Pump Sales Market, By Distribution Channel
      • 6.4.1 Hospitals
      • 6.4.2 Ambulatory Surgical Centers
      • 6.4.3 Specialty Clinics
      • 6.4.4 Homecare Settings
      • 6.4.5 Online Sales
  • 7 Competitive Analysis
    • 7.1 Key Player Comparison
    • 7.2 Market Share Analysis
    • 7.3 Investment Trends
    • 7.4 SWOT Analysis
  • 8 Research Methodology
    • 8.1 Analysis Design
    • 8.2 Research Phases
    • 8.3 Study Timeline
  • 9 Future Market Outlook
    • 9.1 Growth Forecast
    • 9.2 Market Evolution
  • 10 Geographical Overview
    • 10.1 Europe - Market Analysis
      • 10.1.1 By Country
        • 10.1.1.1 UK
        • 10.1.1.2 France
        • 10.1.1.3 Germany
        • 10.1.1.4 Spain
        • 10.1.1.5 Italy
    • 10.2 Asia Pacific - Market Analysis
      • 10.2.1 By Country
        • 10.2.1.1 India
        • 10.2.1.2 China
        • 10.2.1.3 Japan
        • 10.2.1.4 South Korea
    • 10.3 Latin America - Market Analysis
      • 10.3.1 By Country
        • 10.3.1.1 Brazil
        • 10.3.1.2 Argentina
        • 10.3.1.3 Mexico
    • 10.4 North America - Market Analysis
      • 10.4.1 By Country
        • 10.4.1.1 USA
        • 10.4.1.2 Canada
    • 10.5 Middle East & Africa - Market Analysis
      • 10.5.1 By Country
        • 10.5.1.1 Middle East
        • 10.5.1.2 Africa
    • 10.6 Intravenous Infusion Pump Sales Market by Region
  • 11 Global Economic Factors
    • 11.1 Inflation Impact
    • 11.2 Trade Policies
  • 12 Technology & Innovation
    • 12.1 Emerging Technologies
    • 12.2 AI & Digital Trends
    • 12.3 Patent Research
  • 13 Investment & Market Growth
    • 13.1 Funding Trends
    • 13.2 Future Market Projections
  • 14 Market Overview & Key Insights
    • 14.1 Executive Summary
    • 14.2 Key Trends
    • 14.3 Market Challenges
    • 14.4 Regulatory Landscape
Segments Analyzed in the Report
The global Intravenous Infusion Pump Sales market is categorized based on
By Product Type
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Peristaltic Infusion Pumps
  • Ambulatory Infusion Pumps
  • Implantable Infusion Pumps
By Application
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Pediatrics
  • Analgesia
By Distribution Channel
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Homecare Settings
  • Online Sales
By Technology
  • Traditional Infusion Pumps
  • Smart Infusion Pumps
  • Specialty Infusion Pumps
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Medtronic plc
  • Smiths Medical
  • ICU Medical, Inc.
  • Fresenius Kabi AG
  • Terumo Corporation
  • CareFusion Corporation
  • Johnson & Johnson
  • Moog Inc.
  • Halyard Health, Inc.
  • GE Healthcare
  • Philips Healthcare
  • Hospira, Inc.
  • Zyno Medical, LLC
  • Publish Date : Jan 21 ,2025
  • Report ID : ME-61916
  • No. Of Pages : 100
  • Format : |
  • Ratings : 4.5 (110 Reviews)
Buy Report
Buy Report
Connect With Us
What Our Client Say